Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer’s disease mice

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4

Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233 · see citing works

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · see citing works

New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?

Deng, W., Aimone, J. B., & Gage, F. H. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2822 · Cited by 2,120 · see citing works

Regulatory T Cells

Sakaguchi, S. (2000) · Cell · doi:10.1016/s0092-8674(00)80856-9 · Cited by 1,812 · see citing works

Neuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed

Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748 · see citing works

Neuroinflammation: The Devil Is in the Details

DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640 · see citing works

Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,453 · see citing works

Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · see citing works

Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease

Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265 · see citing works

From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery

Banks, W. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.21 · Cited by 1,204 · see citing works

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation

Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B. (2011) · Nature Immunology · doi:10.1038/ni.2027 · Cited by 1,191 · see citing works

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034 · see citing works

Low-grade inflammation, diet composition and health: current research evidence and its translation

Minihane, A. M., Vinoy, S., Russell, W. R., Baka, A., Roche, H. M., Tuohy, K. M., Teeling, J. L., Blaak, E. E., Fenech, M. F., Vauzour, D., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002093 · Cited by 919 · see citing works

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915 · see citing works

The blood-brain barrier in Alzheimer’s disease

Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · see citing works

Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness

Calcia, M., Bonsall, D. R., Bloomfield, P. S., Selvaraj, S., Barichello, T., & Howes, O. D. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4218-9 · Cited by 710 · see citing works

Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology

Spangenberg, E. E., Lee, R. J., Najafi, A. R., Rice, R. A., Elmore, M. R. P., Blurton-Jones, M., West, B. L., & Green, K. N. (2016) · Brain · doi:10.1093/brain/aww016 · Cited by 695 · see citing works

Efficacy of doublecortin as a marker to analyse the absolute number anddendritic growth of newly generated neurons in the adult dentate gyrus

Rao, M. S. R., & Shetty, A. K. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2003.03123.x · Cited by 654 · see citing works

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Gałecki, P., & Leonard, B. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-66 · Cited by 629 · see citing works

GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation

Becher, B., Tugues, S., & Greter, M. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.026 · Cited by 593 · see citing works

Loss of the Presynaptic Vesicle Protein Synaptophysin in Hippocampus Correlates with Cognitive Decline in Alzheimer Disease

SZE, C.-I., TRONCOSO, J. C., KAWAS, C., MOUTION, P., PRICE, D. L., & MARTIN, L. J. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00011 · Cited by 562 · see citing works

Sublime Microglia: Expanding Roles for the Guardians of the CNS

Salter, M. W., & Beggs, S. (2014) · Cell · doi:10.1016/j.cell.2014.06.008 · Cited by 531 · see citing works

Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases

Togo, T., Akiyama, H., Iseki, E., Kondo, H., Ikeda, K., Kato, M., Oda, T., Tsuchiya, K., & Kosaka, K. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00496-9 · Cited by 481 · see citing works

Oxidative stress and the pathogenesis of neurodegenerative disorders.

Reynolds, A. D., Laurie, C., Mosley, R., & Gendelman, H. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82016-2 · Cited by 443 · see citing works

Alzheimer disease models and human neuropathology: similarities and differences

Duyckaerts, C. J., Potier, M., & Delatour, B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 441 · see citing works

Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease

Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., & Mosley, R. L. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507296 · Cited by 422 · see citing works

Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia

Grathwohl, S. A., Kälin, R. E., Bolmont, T., Prokop, S., Winkelmann, G., Kaeser, S. A., Odenthal, J., Radde, R., Eldh, T., Gandy, S., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2432 · Cited by 401 · see citing works

Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease

Masliah, E., Terry, R. D., DeTeresa, R. M., & Hansen, L. A. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90582-x · Cited by 363 · see citing works

Regulatory T cells delay disease progression in Alzheimer-like pathology

Dansokho, C., Ahmed, D. A., Aïd, S., Toly‐Ndour, C., Chaigneau, T., Calle, V., Cagnard, N., Holzenberger, M., Piaggio, E., Aucouturier, P., et al. (2016) · Brain · doi:10.1093/brain/awv408 · Cited by 359 · see citing works

Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survival

Henkel-Tigges, J., Beers, D. R., Wen, S., Rivera, A. L., Toennis, K. M., Appel, J. E., Zhao, W., Moore, D. H., Powell, S. Z.-E., & Appel, S. H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201544 · Cited by 355 · see citing works

Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis

Doens, D., & Fernández, P. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-48 · Cited by 348 · see citing works

CNS-Derived Interleukin-4 Is Essential for the Regulation of Autoimmune Inflammation and Induces a State of Alternative Activation in Microglial Cells

Ponomarev, E. D., Maresz, K., Tan, Y., & Dittel, B. N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1922-07.2007 · Cited by 339 · see citing works

Course of cerebral amyloid angiopathy–related inflammation

Kinnecom, C., Lev, M. H., Wendell, L., Smith, E. E., Rosand, J., Frosch, M. P., & Greenberg, S. M. (2007) · Neurology · doi:10.1212/01.wnl.0000260066.98681.2e · Cited by 333 · see citing works

Adoptive regulatory T‐cell therapy protects against cerebral ischemia

Li, P., Gan, Y., Sun, B., Zhang, F., Lu, B., Gao, Y., Liang, W., Thomson, A. W., Chen, J., & Hu, X. (2012) · Annals of Neurology · doi:10.1002/ana.23815 · Cited by 310 · see citing works

Enrichment enhances spatial memory and increases synaptophysin levels in aged female mice

Frick, K. M., & Fernandez, S. M. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00138-0 · Cited by 303 · see citing works

Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice

Malm, T. M., Koistinaho, M., Pärepalo, M., Vatanen, T., Ooka, A., Karlsson, S., & Koistinaho, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.009 · Cited by 301 · see citing works

Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy

Laurent, C., Dorothée, G., Hunot, S., Martin, E., Monnet, Y., Duchamp, M., Dong, Y., Légeron, F.-P., Leboucher, A., Burnouf, S., et al. (2016) · Brain · doi:10.1093/brain/aww270 · Cited by 299 · see citing works

Amyloid Angiopathy–Related Vascular Cognitive Impairment

Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298 · see citing works

Adult Hippocampal Neurogenesis, Synaptic Plasticity and Memory: Facts and Hypotheses

Bruel‐Jungerman, E., Rampon, C., & Laroche, S. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.2.93 · Cited by 281 · see citing works

Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes

Zuroff, L. R., Daley, D. A., Black, K. L., & Koronyo‐Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 275 · see citing works

Neuroinflammation, Neurodegeneration, and Depression

Hurley, L. L., & Tizabi, Y. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9348-1 · Cited by 260 · see citing works

ALS patients’ regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity

Beers, D. R., Zhao, W., Wang, J., Zhang, X., Wen, S., Neal, D. W., Thonhoff, J. R., Alsuliman, A., Shpall, E. J., Rezvani, K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89530 · Cited by 256 · see citing works

Inflammation and Adaptive Immunity in Parkinson's DiseasePreprint

Mosley, R. L., Hutter-Saunders, J. A. L., Stone, D. K., & Gendelman, H. E. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009381 · Cited by 246 · see citing works

The interleukin-1 receptor family

Boraschi, D., & Tagliabue, A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.023 · Cited by 242 · see citing works

Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease

Jankowsky, J. L., Slunt, H. H., Gonzales, V., Savonenko, A. V., Wen, J. C., Jenkins, N. A., Copeland, N. G., Younkin, L. H., Lester, H. A., Younkin, S. G., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020355 · Cited by 237 · see citing works

Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy

Takeda, S., Sato, N., & Morishita, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00171 · Cited by 226 · see citing works

Granulocyte-Macrophage Colony-Stimulating Factor: Pleiotropic Cytokine with Potential Clinical Usefulness

Ruef, C., & COLEMAN, D. L. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.1.41 · Cited by 224 · see citing works

USP18 lack in microglia causes destructive interferonopathy of the mouse brain

Goldmann, T., Zeller, N., Raasch, J., Kierdorf, K., Frenzel, K., Ketscher, L., Basters, A., Staszewski, O., Brendecke, S. M., Spiess, A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490791 · Cited by 223 · see citing works

Boosting Regulatory T Cells Limits Neuroinflammation in Permanent Cortical Stroke

Liesz, A., Zhou, W., Na, S., Hämmerling, G. J., Garbi, N., Karcher, S., Mracsko, E. Z., Backs, J., Rivest, S., & Veltkamp, R. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4901-12.2013 · Cited by 220 · see citing works

CNS expression of anti‐inflammatory cytokine interleukin‐4 attenuates Alzheimer's disease‐like pathogenesis in APP+PS1 bigenic mice

Kiyota, T., Okuyama, S., Swan, R. J., Jacobsen, M. T., Gendelman, H. E., & Ikezu, T. (2010) · The FASEB Journal · doi:10.1096/fj.10-155317 · Cited by 212 · see citing works

Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients

HNRC, Achim, C. L., Adame, A., Dumaop, W., Everall, I. P., & Masliah, E. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9152-8 · Cited by 205 · see citing works

Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases

Song, G. J., & Suk, K. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00139 · Cited by 199 · see citing works

Dramatic Shifts in Circulating CD4 but not CD8 T Cell Subsets in Mild Alzheimer's Disease

Larbi, A., Pawelec, G., Witkowski, J., Schipper, H., Derhovanessian, E., Goldeck, D., & Fulop, T. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1015 · Cited by 198 · see citing works

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice

Banerjee, R., Mosley, R. L., Reynolds, A. D., Dhar, A., Jackson-Lewis, V. R., Gordon, P. H., Przedborski, S., & Gendelman, H. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002740 · Cited by 198 · see citing works

Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease.

Saresella, M., Calabrese, E., Marventano, I., Piancone, F., Gatti, A., Alberoni, M., Nemni, R., & Clerici, M. (2011) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2010.12.004 · Cited by 181 · see citing works

Early BDNF Treatment Ameliorates Cell Loss in the Entorhinal Cortex of APP Transgenic Mice

Nagahara, A. H., Mateling, M., Kovács, I., Wang, L., Eggert, S., Rockenstein, E. M., Koo, E. H., Masliah, E., & Tuszynski, M. H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5195-12.2013 · Cited by 176 · see citing works

Young microglia restore amyloid plaque clearance of aged microglia

Daria, A., Colombo, A., Llovera, G., Hampel, H., Willem, M., Liesz, A., Haass, C., & Tahirovic, S. (2017) · The EMBO Journal · doi:10.15252/embj.201694591 · Cited by 174 · see citing works

A Neuroprotective Function for the Hematopoietic Protein Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)

Schäbitz, W.-R., Krüger, C., Pitzer, C., Weber, D., Laage, R., Gaßler, N., Aronowski, J. A., Mier, W., Kirsch, F., Dittgen, T., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600496 · Cited by 168 · see citing works

Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model

Baek, H., Ye, M., Kang, G., Lee, C., Lee, G., Choi, D. B., Jung, J., Kim, H., Lee, S., Kim, J. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12469 · Cited by 168 · see citing works

Selective ablation of bone marrow‐derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model

Butovsky, O., Kunis, G., Koronyo‐Hamaoui, M., & Schwartz, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05652.x · Cited by 167 · see citing works

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice

Sanchez‐Ramos, J., Song, S., Sava, V. M., Catlow, B. J., Lin, X., Mori, T., Cao, C., & Arendash, G. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.071 · Cited by 164 · see citing works

Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression.

Molinari, S., Battini, R., Ferrari, S., Pozzi, L., Killcross, S., Robbins, T. W., Jouvenceau, A., Billard, J., Dutar, P., Lamour, Y. A., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8028 · Cited by 160 · see citing works

Functional Maturation of Adult Mouse Resting Microglia into an APC Is Promoted by Granulocyte-Macrophage Colony-Stimulating Factor and Interaction with Th1 Cells

Aloisi, F., Simone, R. D., Cabezas, S. C., Penna, G., & Adorini, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1705 · Cited by 153 · see citing works

Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation

Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0411-8 · Cited by 152 · see citing works

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial

Gendelman, H. E., Zhang, Y., Santamaria, P. M., Olson, K. E., Schutt, C. R., Bhatti, D., Shetty, B. L. D., Lu, Y., Estes, K. A., Standaert, D. G., et al. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0013-5 · Cited by 147 · see citing works

PD1 Negative and PD1 Positive CD4+ T Regulatory Cells in Mild Cognitive Impairment and Alzheimer's Disease

Saresella, M., Calabrese, E., Marventano, I., Piancone, F., Gatti, A. V., Calvo, M. G., Nemni, R., & Clerici, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091696 · Cited by 145 · see citing works

FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders

Kiyota, T., Dixie, K. L. I., Jacobsen, M. T., Xiong, H., & Ikezu, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102349108 · Cited by 145 · see citing works

Treatment Strategies Targeting Amyloid -ProteinPreprint

Schenk, D., Basi, G. S., & Pangalos, M. N. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006387 · Cited by 128 · see citing works

GM-CSF Upregulated in Rheumatoid Arthritis Reverses Cognitive Impairment and Amyloidosis in Alzheimer Mice

Boyd, T. D., Bennett, S. P., Mori, T., Governatori, N., Runfeldt, M., Norden, M., Padmanabhan, J., Neame, P., Wefes, I., Sanchez-Ramos, J., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091471 · Cited by 128 · see citing works

GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice

Kosloski, L. M., Kosmacek, E. A., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.10.009 · Cited by 119 · see citing works

Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L Transgenic Mice

Rutten, B. P. F., van der Kolk, N. M., Schäfer, S., van Zandvoort, M. A. M. J., Bayer, T. A., Steinbusch, H. W. M., & Schmitz, C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62963-x · Cited by 115 · see citing works

Granulocyte-macrophage colony-stimulating factor crosses the blood-- brain and blood--spinal cord barriers

McLay, R. N. (1997) · Brain · doi:10.1093/brain/120.11.2083 · Cited by 109 · see citing works

T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer’s Disease: Potential Pools of New Biomarkers

Mietelska‐Porowska, A., & Wojda, U. (2017) · Journal of Immunology Research · doi:10.1155/2017/4626540 · Cited by 107 · see citing works

ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain

Fu, Y., Hsiao, J.-H. T., Paxinos, G., Halliday, G. M., & Kim, W. S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160456 · Cited by 98 · see citing works

Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease

Ye, M., Chung, H., Lee, C., Yoon, M. S., Yu, A., Kim, J. S., Hwang, D., Shim, I., & Bae, H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0476-z · Cited by 92 · see citing works

CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease

Kiyota, T., Gendelman, H. E., Weir, R. A., Higgins, E. E., Zhang, G., & Jain, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.009 · Cited by 90 · see citing works

The role of regulatory T cells in nervous system pathologies

Duffy, S. S., Keating, B. A., Perera, C. J., & Moalem‐Taylor, G. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24073 · Cited by 85 · see citing works

Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders

Anderson, K. M., Olson, K. E., Estes, K. A., Flanagan, K., Gendelman, H. E., & Mosley, R. L. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-25 · Cited by 81 · see citing works

Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?

Mahgoub, N., & Alexopoulos, G. S. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.12.003 · Cited by 81 · see citing works

The innate immune system in Alzheimer's disease

Boutajangout, A., & Wisniewski, T. (2013) · International Journal of Cell Biology · doi:10.1155/2013/576383 · Cited by 69 · see citing works

Differentiation driven by granulocyte-macrophage colony-stimulating factor endows microglia with interferon-γ-independent antigen presentation function

Fischer, H., Nitzgen, B., Germann, T., Degitz, K., Däubener, W., & Hadding, U. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90215-k · Cited by 69 · see citing works

Lifelong immunization with human β-amyloid (1–42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging

Jensen, M. T., Mottin, M. D., Cracchiolo, J. R., Leighty, R. E., & Arendash, G. W. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.055 · Cited by 69 · see citing works

AAV1/2-mediated CNS Gene Delivery of Dominant-negative CCL2 Mutant Suppresses Gliosis, β-amyloidosis, and Learning Impairment of APP/PS1 Mice

Kiyota, T., Yamamoto, M., Schroder, B., Jacobsen, M. T., Swan, R. J., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · Molecular Therapy · doi:10.1038/mt.2009.44 · Cited by 68 · see citing works

Alzheimer's disease: Innate immunity gone awry?

VanItallie, T. B. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.014 · Cited by 67 · see citing works

Granulocyte-Macrophage Colony-Stimulating Factor Is Neuroprotective in Experimental Traumatic Brain Injury

Shultz, S. R., Tan, X. L., Wright, D. K., Liu, S. J., Semple, B. D., Johnston, L. A., Jones, N. C., Cook, A. D., Hamilton, J. A., & O'Brien, T. J. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3106 · Cited by 66 · see citing works

Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients

Page, A. Y. L., Garneau, H., Dupuis, G., Frost, E. H., Larbi, A., Witkowski, J. M., Pawelec, G., & Fülöp, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00783 · Cited by 65 · see citing works

Granulocyte macrophage colony‐stimulating factor treatment of a patient in myasthenic crisis: Effects on regulatory T cells

Rowin, J., Thiruppathi, M., Arhebamen, E., Sheng, J., Prabhakar, B. S., & Meriggioli, M. N. (2012) · Muscle & Nerve · doi:10.1002/mus.23488 · Cited by 64 · see citing works

Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations

Puligujja, P., Balkundi, S. S., Kendrick, L. M., Baldridge, H. M., Hilaire, J. R., Bade, A. N., Dash, P. K., Zhang, G., Poluektova, L. Y., Gorantla, S., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.11.012 · Cited by 63 · see citing works

Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease

Olson, K. E., & Gendelman, H. E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.10.006 · Cited by 63 · see citing works

Targeting GM-CSF in rheumatoid arthritis.

Avcı, A. B., Feist, E., & Burmester, G. (2016) · PubMed · Cited by 63 · see citing works

Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer’s Disease (3xTg-AD)

Minh, T. N., Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J., Farinotti, R., & Bourasset, F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150350 · Cited by 60 · see citing works

GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis

Sheng, J. R., Thiruppathi, M., Prabhakar, B. S., & Meriggioli, M. N. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.10.010 · Cited by 52 · see citing works

CD 4+ T cells in the pathobiology of neurodegenerative disorders

Huang, X., Reynolds, A. D., Mosley, R. L., & Gendelman, H. E. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.04.006 · Cited by 51 · see citing works

T Cells—Protective or Pathogenic in Alzheimer’s Disease?

McManus, R. M., Mills, K. H. G., & Lynch, M. A. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9612-2 · Cited by 50 · see citing works

Kallikrein‐8 inhibition attenuates Alzheimer's disease pathology in mice

Herring, A., Münster, Y., Akkaya, T., Moghaddam, S. H., Deinsberger, K., Meyer, J., Zahel, J., Sánchez-Mendoza, E. H., Wang, Y., Hermann, D. M., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.05.006 · Cited by 48 · see citing works

Intracarotid injection of granulocyte–macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model

Nakagawa, T., Suga, S., Kawase, T., & Toda, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.059 · Cited by 44 · see citing works

Old Friends in New Constellations - the Hematopoetic Growth Factors G-CSF, GMCSF, and EPO for the Treatment of Neurological Diseases

Maurer, M. H., Schäbitz, W., & Schneider, A. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784567671 · Cited by 44 · see citing works

A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders

Gendelman, H. E., & Mosley, R. L. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9639-4 · Cited by 43 · see citing works

The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions

Krieger, M., Both, M., Kranig, S. A., Pitzer, C., Klugmann, M., Vogt, G., Draguhn, A., & Schneider, A. (2012) · Scientific Reports · doi:10.1038/srep00697 · Cited by 42 · see citing works

Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases

Kosloski, L. M., Ha, D. M., Hutter-Saunders, J. A. L., Stone, D. K., Pichler, M. R., Reynolds, A. D., Gendelman, H. E., & Mosley, R. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06834.x · Cited by 40 · see citing works

Granulocyte Macrophage Colony-Stimulating Factor: Current Practice and Novel Approaches

Buchsel, P. C., Forgey, A., Grape, F. B., & Hamann, S. S. (2002) · Clinical journal of oncology nursing · doi:10.1188/02.cjon.198-205 · Cited by 39 · see citing works

Granulocyte-Macrophage Colony Stimulating Factor Exerts Protective and Immunomodulatory Effects in Cortical Trauma

Kelso, M. L., Elliott, B. R., Haverland, N. A., Mosley, R. L., & Gendelman, H. E. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.11.002 · Cited by 39 · see citing works

The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer’s Disease

Muszyński, P., Kulczyńska‐Przybik, A., Borawska, R., Litman‐Zawadzka, A., Słowik, A., Klimkowicz‐Mrowiec, A., Pera, J., Dziedzic, T., & Mroczko, B. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170220 · Cited by 38 · see citing works

Proliferation of a Subpopulation of Human Peripheral Blood Monocytes in the Presence of Colony Stimulating Factors may Contribute to the Inflammatory Process in Diseases such as Rheumatoid Arthritis

Moss, S. T., & Hamilton, J. A. (2000) · Immunobiology · doi:10.1016/s0171-2985(00)80048-0 · Cited by 32 · see citing works

Functional Proteomic Analysis for Regulatory T Cell Surveillance of the HIV-1-Infected Macrophage

Huang, X., Stone, D. K., Yu, F., Zeng, Y., & Gendelman, H. E. (2010) · Journal of Proteome Research · doi:10.1021/pr1009178 · Cited by 30 · see citing works

Granulocyte–macrophage colony‐stimulating factor regulates cytokine production in cultured macrophages through CD14‐dependent and ‐independent mechanisms

Bergamini, A., Bolacchi, F., Bongiovanni, B., Cepparulo, M., Ventura, L., Capozzi, M., Sarrecchia, C., & Rocchi, G. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00117.x · Cited by 29 · see citing works

Human Umbilical Cord Blood-Derived Monocytes Improve Cognitive Deficits and Reduce Amyloid-β Pathology in PSAPP Mice

Darlington, D., Li, S., Hou, H., Habib, A., Tian, J., Gao, Y., Ehrhart, J. C., Sanberg, P. R., Sawmiller, D. R., Giunta, B. N., et al. (2015) · Cell Transplantation · doi:10.3727/096368915x688894 · Cited by 28 · see citing works

MHC-Independent Genetic Factors Control the Magnitude of CD4+ T Cell Responses to Amyloid-β Peptide in Mice through Regulatory T Cell-Mediated Inhibition

Toly‐Ndour, C., Lui, G., Nunes, M. M., Bruley-Rosset, M., Aucouturier, P., & Dorothée, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003953 · Cited by 25 · see citing works

Neuroprotection of Granulocyte Colony-Stimulating Factor for Early Stage Parkinson's Disease

Tsai, S., Chu, S.-C., Liu, S., Pang, C., Hou, T.-W., Lin, S., & Chen, S.-Y. (2017) · Cell Transplantation · doi:10.3727/096368916x694247 · Cited by 24 · see citing works

Exploring Erythropoietin and G-CSF Combination Therapy in Chronic Stroke Patients

Shin, Y., & Cho, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040463 · Cited by 23 · see citing works

Intravenous Infusion of Monocytes Isolated from 2-Week-Old Mice Enhances Clearance of Beta-Amyloid Plaques in an Alzheimer Mouse Model

Hohsfield, L. A., & Humpel, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121930 · Cited by 21 · see citing works

Presenilin-1 familial Alzheimer’s disease mutation alters hippocampal neurogenesis and memory function in CCL2 null mice

Kiyota, T., Morrison, C. M., Tu, G., Dyavarshetty, B., Weir, R. A., Zhang, G., Xiong, H., & Gendelman, H. E. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.014 · Cited by 19 · see citing works

The Toll-like receptor 4-activated neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling

Kamigaki, M., Hide, I., Yanase, Y., Shiraki, H., Harada, K., Tanaka, Y., Seki, T., Shirafuji, T., Tanaka, S., Hide, M., et al. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.01.003 · Cited by 19 · see citing works

Synthes Award for Resident Research on Spinal Cord and Spinal Column Injury: granulocyte macrophage colony stimulating factor (GM-CSF) prevents apoptosis and improves functional outcome in experimental spinal cord contusion injury.

Ha, Y. S., Park, H. S., Park, C. W., Yoon, S. H., Park, S. R., Hyun, D. K., Kim, E. Y., & Park, H. C. (2005) · PubMed · Cited by 15 · see citing works

Granulocyte-Colony Stimulating Factor Attenuates Oligomeric Amyloid β Neurotoxicity by Activation of Neprilysin

Doi, Y., Takeuchi, H., Mizoguchi, H., Fukumoto, K., Horiuchi, H., Jin, S., Kawanokuchi, J., Parajuli, B., Sonobe, Y., Mizuno, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103458 · Cited by 11 · see citing works

Aβ and Inflammatory Stimulus Activate Diverse Signaling Pathways in Monocytic Cells: Implications in Retaining Phagocytosis in Aβ-Laden Environment

Savchenko, E., Malm, T., Konttinen, H., Hämäläinen, R. H., Guerrero-Toro, C., Wojciechowski, S., Giniatullin, R. A., Koıstınaho, J., & Magga, J. M. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00279 · Cited by 9 · see citing works

Acute granulocyte macrophage-colony stimulating factor treatment modulates neuroinflammatory processes and promotes tactile recovery after spinal cord injury

Thomaty, S., Pézard, L., Xerri, C., & Brezun, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.035 · Cited by 9 · see citing works

Untitled work

(1999) · doi:10.1002/(sici)1098-1063(1999)9:5

Synaptic degeneration in Alzheimer disease

Tzioras, M., McGeachan, R. I., Durrant, C. S., & Spires-Jones, T. L. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00749-z · Cited by 504 · see citing works

Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances

Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165 · see citing works

CD4+ effector T cells accelerate Alzheimer’s disease in mice

Machhi, J., Yeapuri, P., Lu, Y., Foster, E. G., Chikhale, R. V., Herskovitz, J., Namminga, K. L., Olson, K. E., Abdelmoaty, M. M., Gao, J., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02308-7 · Cited by 147 · see citing works

Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer’s Disease: Mechanisms, Drug Candidates, and New Opportunities

Fu, W., Wang, X., & Ip, N. Y. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00402 · Cited by 136 · see citing works

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders

Machhi, J., Kevadiya, B. D., Muhammad, I. K., Herskovitz, J., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00375-7 · Cited by 136 · see citing works

Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification

Cummings, J. L., Osse, A. M. L., & Kinney, J. W. (2023) · Drugs · doi:10.1007/s40265-023-01938-w · Cited by 123 · see citing works

Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease

Uddin, M. S., Kabir, M. T., Mamun, A. A., Barreto, G. E., Rashid, M., Perveen, A., & Ashraf, G. M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106479 · Cited by 115 · see citing works

Immunotherapies for Neurodegenerative Diseases

Mortada, I., Farah, R., Nabha, S. M., Ojcius, D. M., Fares, Y., Almawi, W. Y., & Sadier, N. S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.654739 · Cited by 112 · see citing works

Immunotherapy for Parkinson’s disease

Schwab, A. D., Thurston, M. J., Machhi, J., Olson, K. E., Namminga, K. L., Gendelman, H. E., & Mosley, R. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104760 · Cited by 98 · see citing works

Activation of group 2 innate lymphoid cells alleviates aging-associated cognitive decline

Fung, I. T. H., Sankar, P., Zhang, Y., Robison, L. S., Zhao, X., D’Souza, S. S., Salinero, A. E., Wang, Y., Qian, J., Kuentzel, M. L., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190915 · Cited by 97 · see citing works

Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease

Potter, H., Woodcock, J. H., Boyd, T. D., Coughlan, C. M., O'Shaughnessy, J. R., Borges, M. T., Thaker, A. A., Raj, B. A., Adamszuk, K., Scott, D., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12158 · Cited by 94 · see citing works

Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease

Yang, H., Park, S., Baek, H., Lee, C., Chung, G., Liu, X., Lee, J. H., Kim, B., Kwon, M., Choi, H.-J., et al. (2022) · Theranostics · doi:10.7150/thno.75965 · Cited by 80 · see citing works

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Yeapuri, P., Machhi, J., Lu, Y., Abdelmoaty, M. M., Kadry, R., Patel, M., Bhattarai, S., Lu, E., Namminga, K. L., Olson, K. E., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00692-7 · Cited by 78 · see citing works

Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

Melchiorri, D., Merlo, S., Micallef, B., Borg, J.-J., & Dráfi, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1196413 · Cited by 72 · see citing works

Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?

Lazarus, H. M., Ragsdale, C. E., Gale, R. P., & Lyman, G. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.706186 · Cited by 69 · see citing works

Gamma Visual Stimulation Induces a Neuroimmune Signaling Profile Distinct from Acute Neuroinflammation

Garza, K. M., Zhang, L., Borron, B. M., Wood, L. B., & Singer, A. C. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1511-19.2019 · Cited by 67 · see citing works

Immune mechanisms and shared immune targets in neurodegenerative diseases

Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 63 · see citing works

Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease

Olson, K. E., Namminga, K. L., Lu, Y., Thurston, M. J., Schwab, A. D., de Picciotto, S., Tse, S., Walker, W., Iacovelli, J., Small, C. G., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120786 · Cited by 56 · see citing works

Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers

Kreiser, R. P., Wright, A. K., Block, N. R., Hollows, J. E., Nguyen, L. T., LeForte, K., Mannini, B., Vendruscolo, M., & Limbocker, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228651 · Cited by 47 · see citing works

Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders

Marchi, F. D., Munitić, I., Vidatic, L., Papić, E., Rački, V., Nimac, J., Jurak, I., Novotni, G., Rogelj, B., Vuletić, V., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102793 · Cited by 46 · see citing works

Drug Repositioning for Alzheimer’s Disease: Finding Hidden Clues in Old Drugs

Ihara, M., & Saitô, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200049 · Cited by 45 · see citing works

L-carnitine and Co Q10 ameliorate potassium dichromate -induced acute brain injury in rats targeting AMPK/AKT/NF-κβ

Salama, A., & Elgohary, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107867 · Cited by 41 · see citing works

Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?

Ahmed, M. M., Johnson, N. R., Boyd, T. D., Coughlan, C. M., Chial, H. J., & Potter, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.718426 · Cited by 41 · see citing works

Development of an extended half-life GM-CSF fusion protein for Parkinson's disease

Yeapuri, P., Olson, K. E., Lu, Y., Abdelmoaty, M. M., Namminga, K. L., Marković, M., Machhi, J., Mosley, R. L., & Gendelman, H. E. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.024 · Cited by 36 · see citing works

An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers

Olson, K. E., Abdelmoaty, M. M., Namminga, K. L., Lu, Y., Obaro, H., Santamaria, P. M., Mosley, R. L., & Gendelman, H. E. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00361-1 · Cited by 36 · see citing works

Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice

Olson, K. E., Namminga, K. L., Schwab, A. D., Thurston, M. J., Lu, Y., Woods, A. C., Lei, L., Shen, W., Wang, F., Joseph, S. B., et al. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00877-8 · Cited by 35 · see citing works

Europium-Doped Cerium Oxide Nanoparticles for Microglial Amyloid Beta Clearance and Homeostasis

Machhi, J., Yeapuri, P., Marković, M., Patel, M., Yan, W., Lu, Y., Cohen, J. D., Hasan, M., Abdelmoaty, M. M., Zhou, Y., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00847 · Cited by 34 · see citing works

The mitochondrial protein TSPO in Alzheimer’s disease: relation to the severity of AD pathology and the neuroinflammatory environment

Garland, E. F., Dennett, O., Lau, L. C., Chatelet, D. S., Bottlaender, M., Nicoll, J. A. R., & Boche, D. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02869-9 · Cited by 32 · see citing works

Mechanism of microglia-mediated neuroinflammation, associated cognitive dysfunction, and therapeutic updates in Alzheimer's disease

Ghimire, A., Rehman, S. A., Subhani, A., Khan, M. A., Rahman, Z., Iqubal, M. K., & Iqubal, A. (2025) · hLife · doi:10.1016/j.hlife.2024.11.006 · Cited by 30 · see citing works

Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease?

Munafò, A., Burgaletto, C., Benedetto, G. D., Mauro, M. D., Mauro, R. D., Bernardini, R., & Cantarella, G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614643 · Cited by 27 · see citing works

Diverse functions and mechanisms of regulatory T cell in ischemic stroke.

Wu, Y., Li, J., Shou, J.-Y., Zhang, W.-G., & Chen, C.-H. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113782 · Cited by 21 · see citing works

The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice

Ahmed, M. M., Wang, A. C., Elos, M. T., Chial, H. J., Sillau, S., Solano, D. A., Coughlan, C. M., Aghili, L., Anton, P. E., Markham, N. E., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105694 · Cited by 30 · see citing works

Elevated inflammatory proteins in cerebrospinal fluid from patients with painful knee osteoarthritis are associated with reduced symptom severity

Palada, V., Ahmed, A. S., Freyhult, E., Hugo, A. K., Kultima, K., Svensson, C. I., & Kosek, E. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577391 · Cited by 26 · see citing works

The genetics of circulating BDNF: towards understanding the role of BDNF in brain structure and function in middle and old ages

Li, S., Weinstein, G., Zare, H., Teumer, A., Völker, U., Friedrich, N., Knol, M. J., Satizábal, C. L., Petyuk, V., Adams, H. H. H., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa176 · Cited by 26 · see citing works

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease

de la Monte, S. M., Tong, M., & Hapel, A. J. (2023) · Biomedicines · doi:10.3390/biomedicines11092394 · Cited by 27 · see citing works

Targeting Microglial Population Dynamics in Alzheimer’s Disease: Are We Ready for a Potential Impact on Immune Function?

Martin-Estebane, M., & Gomez-Nicola, D. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00149 · Cited by 25 · see citing works

Differential roles of regulatory T cells in Alzheimer's disease

Jafarzadeh, A., Sheikhi, A., Jafarzadeh, Z., & Nemati, M. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104778 · Cited by 24 · see citing works

Therapeutic anti‐amyloid β antibodies cause neuronal disturbances

Adhikari, U. K., Khan, R. H., Mikhael, M., Balez, R., David, M. A., Mahns, D. A., Hardy, J., & Tayebi, M. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12833 · Cited by 24 · see citing works

Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease

Marković, M., Yeapuri, P., Namminga, K. L., Lu, Y., Saleh, M., Olson, K. E., Gendelman, H. E., & Mosley, R. L. (2022) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2022-0001 · Cited by 21 · see citing works

Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer’s Disease

Weber, G. E., Khrestian, M., Tuason, E. D., Shao, Y. Y., Pillai, J. A., Rao, S. M., Feng, H., Zhou, Y., Cheng, F., DeSilva, T. M., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100771 · Cited by 21 · see citing works

Regulatory T Cell Therapeutics for Neuroinflammatory Disorders

Harkins, A. L., Kopec, A. L., & Keeler, A. M. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2022045080 · Cited by 19 · see citing works

Exploring causal correlations between systemic inflammatory cytokines and epilepsy: A bidirectional Mendelian randomization study

Sun, H., Ma, D., Hou, S., Zhang, W., Li, J., Zhao, W., Shafeng, N., & Meng, H. (2023) · Seizure · doi:10.1016/j.seizure.2023.11.006 · Cited by 14 · see citing works

Rheumatoid arthritis is a protective factor against Alzheimer’s disease: a bidirectional two-sample Mendelian randomization study

Li, G.-S., Yang, Y.-Z., Ma, G., Li, P., Cheng, Q.-H., Zhang, A.-R., Zhang, Z.-Z., Zhang, F.-K., Yang, X., Fan, H., et al. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01397-5 · Cited by 13 · see citing works

Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19

Potter, H., Boyd, T. D., Clarke, P., Pelak, V. S., & Tyler, K. L. (2020) · F1000Research · doi:10.12688/f1000research.23729.1 · Cited by 11 · see citing works

Hypoxic-ischemic brain injury in neonatal mice sequentially recruits neutrophils with dichotomous phenotype and function

Richter, M., Diesterbeck, E., Pylaeva, E., Labusek, N., Köster, C., Nagel, D., Karsch, L., Fischer, A. J., Sous, M., Jung, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65517-1 · Cited by 10 · see citing works

Neurological risks and benefits of cytokine‐based treatments in coronavirus disease 2019: from preclinical to clinical evidence

Pignataro, G., Cataldi, M., & Taglialatela, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15397 · Cited by 9 · see citing works

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity

Pykhtina, M., Miroshnichenko, S. M., Romanov, V., Grazhdantseva, A. A., Kochneva, G. V., & Борисович, Б. А. (2021) · Pharmaceuticals · doi:10.3390/ph14050459 · Cited by 8 · see citing works

Single-Cell RNA Sequencing Reveals Immunomodulatory Effects of Stem Cell Factor and Granulocyte Colony-Stimulating Factor Treatment in the Brains of Aged APP/PS1 Mice

Gardner, R. S., Kyle, M. M., Hughes, K., & Zhao, L. (2024) · Biomolecules · doi:10.3390/biom14070827 · Cited by 7 · see citing works

Granulocyte-macrophage colony-stimulating factor-triggered innate immune tolerance against chronic stress-induced behavioral abnormalities in mice

Chen, Z., Liu, H., Ye, Y., Chen, D., Lu, Q., Lu, X., & Huang, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108924 · Cited by 6 · see citing works

Phrenic nerve stimulation mitigates hippocampal and brainstem inflammation in an ARDS model

Bassi, T. G., Rohrs, E. C., Fernandez, K. C., Ornowska, M., Nicholas, M., Wittmann, J., Gani, M., Evans, D., & Reynolds, S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1182505 · Cited by 6 · see citing works

GM-CSF Promotes Immune Response and Survival in a Mouse Model of COVID-19Preprint

Kendall, L. V., Boyd, T. D., Sillau, S., Bosco‐Lauth, A. M., Markham, N. E., Fong, D. L., Clarke, P., Tyler, K. L., & Potter, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1213395/v1 · Cited by 6 · see citing works

Conditioned media of mouse macrophages modulates neuronal dynamics in mouse hippocampal cells

Öztürk, A. B., Öztürk, N. C., & Ayaz, F. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109548 · Cited by 5 · see citing works

Neuroprotection in Alzheimer Disease

Jain, K. K. (2019) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4939-9465-6_8 · Cited by 5 · see citing works

Pro-inflammatory Cytokine GM-CSF Improves Learning/Memory and Brain Pathology in Dp16 Down Syndrome Mice and Improves Learning/Memory in Wild-Type MicePreprint

Ahmed, M. M., Wang, A. C.-J., Elos, M. T., Chial, H. J., Sillau, S. H., Solano, D., Coughlan, C. M., Aghili, L., Anton, P., Markham, N., et al. (2021) · bioRxiv · doi:10.1101/2021.07.04.451073 · Cited by 2 · see citing works

A Trisomy 21-linked Hematopoietic Gene Variant in Microglia Confers Resilience in Human iPSC Models of Alzheimer’s DiseasePreprint

Jin, M., Ma, Z., Dang, R., Zhang, H., Kim, R., Xue, H., Pascual, J. R., Finkbeiner, S. M., Head, E., Liu, Y. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.12.584646 · Cited by 5 · see citing works

Shared interactions of six neurotropic viruses with 38 human proteins: a computational and literature-based exploration of viral interactions and hijacking of human proteins in neuropsychiatric disorders

Ozer, E. A., Keskin, A., Berrak, Y. H., Cankara, F., Can, F., Özdemir, Y., Keskin, Ö., Gürsoy, A., & Eser, H. Y. (2025) · Discover Mental Health · doi:10.1007/s44192-025-00128-2 · Cited by 4 · see citing works

Pathophysiology of Alzheimer’s Disease: Focus on H3 Receptor Modulators and Their Implications

Bandaru, N., Bukke, S. P. N., Pedapati, V. M. D., Sowjanaya, G., Suggu, V. S., Nalla, S., Dudhe, P. B., Ezeonwumelu, J. O. C., Alagbonsi, A. I., & Onohuean, H. (2025) · Drugs and Drug Candidates · doi:10.3390/ddc4020022 · Cited by 4 · see citing works

Exploring Imaging Genetic Markers of Alzheimer’s Disease Based on a Novel Nonlinear Correlation Analysis Algorithm

Yang, R., Kong, W., Liu, K., Wen, G., & Yu, Y. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02190-x · Cited by 4 · see citing works

Neuroimmune Dysfunction in Alzheimer’s Disease and Other Forms of Dementia

Yamane, T., Yoshioka, T., & Shimo, Y. (2024) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c23-00464 · Cited by 4 · see citing works

Neuron loss in the brain starts in childhood, increases exponentially with age and is halted by GM-CSF treatment in Alzheimer’s diseasePreprint

Sillau, S., Coughlan, C. M., Ahmed, M. M., Nair, K. V., Araya, P., Galbraith, M. D., Bettcher, B. M., Espinosa, J. M., Chial, H. J., Epperson, N., et al. (2024) · medRxiv · doi:10.1101/2024.07.14.24310223 · Cited by 4 · see citing works

Controversies and insights into cytokine regulation of neurogenesis and behavior in adult rodents

Sepúlveda-Cuéllar, R. D., Soria-Medina, D. A., Cañedo-Solares, I., Gómez‐Chávez, F., Molina-López, L. M., Cruz, Y., & Correa, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550660 · Cited by 3 · see citing works

Blood measure of neuronal death is exponentially higher with age, especially in females, and halted in Alzheimer’s disease by GM-CSF treatment

Sillau, S., Coughlan, C. M., Ahmed, M. M., Nair, K. V., Araya, P., Galbraith, M. D., Ritchie, A. M., Wang, A. C., Elos, M. T., Bettcher, B. M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102525 · Cited by 3 · see citing works

Dissecting the effect of blood colony-stimulating factors and receptors on Alzheimer's disease: the role of myeloid traits and inflammation

Guo, X., Tang, P., He, J., & Li, R. (2025) · Cytokine · doi:10.1016/j.cyto.2025.157072 · Cited by 2 · see citing works

A myeloid trisomy 21-associated gene variant is protective from Alzheimer’s disease

Jin, M., Ma, Z., Dang, R., Zhang, H., Kim, R., Xue, H., Pascual, J. R., Yu, H., Papetti, A. V., Liú, Y., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02117-8 · Cited by 9 · see citing works

Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force

Siemers, E. (2019) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2019.19 · Cited by 2 · see citing works

Neuroprotective Immunity for Neurodegenerative and Neuroinfectious Diseases

Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-33946-3_8 · Cited by 2 · see citing works

Growth factors and their receptors

Lazaldin, M. A. M., Lambuk, L., Ahmad, S., & Mohamud, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00005-1 · Cited by 1 · see citing works

Immunomodulation as a Treatment for Parkinson‘s Disease in Current Trials: A Systematic Review and Meta-Analysis

Vega-Angeles, V. T., Morales-Ruiz, V., & Adalid-Peralta, L. V. (2024) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.24000068 · Cited by 1 · see citing works

Hypothalamic and hippocampal transcriptome changes in AppNL-G-F mice as a function of metabolic and inflammatory dysfunction

Rico, E. M. G., Joseph, P., Noutsos, C., & Poon, K. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.007 · Cited by 1 · see citing works

Reevaluation of EPO and its Derivatives Centering on β Common ReceptorPreprint

Luo, Y., Wang, R., & Yang, Z. (2024) · doi:10.22541/au.170667577.79095000/v1

A Neuroinflammatory View of Alzheimer’s Disease

Anisman, H., Hayley, S. P., & Kusnecov, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.00005-3

References

(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.09996-8

Intrauterine Growth Restriction Alters Postnatal Hippocampal Dentate Gyrus Neuron and Microglia Morphology and Cytokine/Chemokine Milieu in Mice

Strnad, F. A., Brown, A. S., Wieben, M., Cortes-Sanchez, E., Williams, M. E., & Fung, C. M. (2024) · Life · doi:10.3390/life14121627

Immune Transformations for Therapeutic Gain in Neurodegenerative Disease

Sapkota, R., & Mosley, R. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_50

Anti-inflammatory and immunomodulating agents

Britten, J. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00014-4

Additional file 1 of An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers

Olson, K. E., Abdelmoaty, M. M., Namminga, K. L., Lu, Y., Obaro, H., Santamaria, P. M., Mosley, R. L., & Gendelman, H. E. (2024) · Figshare · doi:10.6084/m9.figshare.26590808

Additional file 2 of An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers

Olson, K. E., Abdelmoaty, M. M., Namminga, K. L., Lu, Y., Obaro, H., Santamaria, P. M., Mosley, R. L., & Gendelman, H. E. (2024) · Figshare · doi:10.6084/m9.figshare.26590811

Additional file 1 of Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

Yeapuri, P., Machhi, J., Lu, Y., Abdelmoaty, M. M., Kadry, R., Patel, M., Bhattarai, S., Lu, E., Namminga, K. L., Olson, K. E., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24864141

Can we refute a role for infections in Alzheimer's disease pathogenesis?

Chatila, Z. K., Duggan, M. R., Silberberg, E., y Fernández, J. R. M., Auber, L. A., Bradshaw, E. M., & Schultek, N. M. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71288

Modulating brain immunity with recombinant proteins

Pathikonda, S., & Arava, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44631-3.00009-3

Stem cells and derived growth factors in Alzheimer’s disease: mechanistic insights and translational perspectives

Dhapola, R., Kumari, S., Sharma, P., Paidlewar, M., Vellingiri, B., Cho, S.-G., Dayem, A. A., Medhi, B., & HariKrishnaReddy, D. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02418-9

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice

Sanchez‐Ramos, J., Song, S., Sava, V. M., Catlow, B. J., Lin, X., Mori, T., Cao, C., & Arendash, G. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.071 · Cited by 164 · see citing works

Granulocyte‐Macrophage Colony‐Stimulating Factor Reduces Two Major Pathological Hallmarks of Alzheimer’s Disease and Astrogliosis in the TgF344‐AD Rat Model

Ahmed, M. M., Wang, A. C., Boyd, T. D., Solano, D. A., Vielle, A., Markham, N. E., Coughlan, C. M., Chial, H. J., Vergara, M. N., & Potter, H. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.067785

Examining the immunomodulatory effects of GM‐CSF and IL‐12 in a mouse model of Alzheimer’s disease (728.2)

Schettler, S. P., Klaidman, L. K., Vinters, H. V., & Stark, E. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.728.2 · Cited by 1 · see citing works

Granulocyte colony stimulating factor (GCSF) improves memory and neurobehavior in an amyloid-β induced experimental model of Alzheimer's disease

Prakash, A., Medhi, B., & Chopra, K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.015 · Cited by 81 · see citing works

GM-CSF Upregulated in Rheumatoid Arthritis Reverses Cognitive Impairment and Amyloidosis in Alzheimer Mice

Boyd, T. D., Bennett, S. P., Mori, T., Governatori, N., Runfeldt, M., Norden, M., Padmanabhan, J., Neame, P., Wefes, I., Sanchez-Ramos, J., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091471 · Cited by 128 · see citing works